Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-041514

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 31, 2018
Accepted (ET)
Aug 2, 2018 · 6:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F3,F4,F1$8.93Jul 31, 2018A24,000A—Jul 31, 2028Common Stock24,00024,000D

Explanation of responses